NI Zhao Hui, MD, PhD, Chief Physician, Professor, Doctoral Supervisor, and Postdoctoral Supervisor. Currently, she serves as the Director of the Department of General Internal Medicine, Director of Internal Medicine Residency Training, and Director of Internal Medicine Teaching and Research at Renji Hospital affiliated to Shanghai Jiao Tong University School of Medicine. She is also the Chief Expert and the Chief Professor of Integrated Medicine for the Urinary System at the Shanghai Jiao Tong University School of Medicine. Dr. NI has been engaged in clinical and experimental research in the Department of Nephrology at Renji Hospital affiliated to Shanghai Jiao Tong University School of Medicine since 1983, accumulating rich clinical experience in nephrology and internal medicine. She served as the Director of the Department of Nephrology at Renji Hospital affiliated to Shanghai Jiao Tong University School of Medicine from 2004 to 2020. In 2005 and 2006, she was a visiting scholar at the Yale University School of Medicine VA Medical Center and Brigham and Women’s Hospital and Harvard Medical School in the United States.

Dr. NI has been involved in clinical and basic research on the prevention and treatment of acute and chronic kidney diseases. She is skilled in diagnosing and treating various difficult and complicated kidney diseases, including IgA nephropathy, diabetic nephropathy, hypertensive nephrosclerosis, nephrotic syndrome, lupus nephritis, chronic renal insufficiency, hyperuricemia, gouty nephropathy, hematuria, and urinary tract infections. She is particularly adept at integrating traditional Chinese medicine with Western medicine in the treatment of these kidney diseases, including peritoneal dialysis and hemodialysis.

In recent years, Dr. NI has been responsible for and has obtained numerous national and provincial-level scientific research projects. As one of the 41 experts in the field of nephrology nationwide, she was selected for the 2024 list of the top 2% scientists in the fields of urology and nephrology (released jointly by Stanford University and the international authoritative publisher Elsevier) and was also included in the 2024 annual pre-release list of the top 1% highly cited scholars by China National Knowledge Infrastructure (CNKI). She has published over 300 academic papers, including more than 100 SCI papers, and has edited or co-edited 14 monographs. She served as the first deputy editor for the Standard Operating Procedures for Peritoneal Dialysis and as a core member of the editorial committee for the Chinese Expert Consensus on the Integrated Treatment of IgA Nephropathy, the Guidelines for the Integrated Prevention and Treatment of Chronic Renal Failure, and the Guidelines for the Integrated Diagnosis and Treatment of Diabetic Nephropathy.

Dr. NI holds various social positions, including Honorary Chairman of the Shanghai Medical Association Nephrology Branch, Chairman of the Shanghai Integrated Chinese and Western Medicine Association Metabolic and Immune Nephropathy Committee, Vice Chairman of the Shanghai Integrated Chinese and Western Medicine Association Expert Committee, Former Chairman of the Shanghai Integrated Chinese and Western Medicine Nephrology Branch, Vice Chairman of the Second Shanghai Hospital Management Association Blood Purification Branch, Standing Committee Member of the Ninth, Tenth, and Eleventh Sessions of the Chinese Medical Association Nephrology Branch, Standing Committee Member of the Third and Fourth Sessions of the Chinese Physician Association Nephrology Branch, Secretary-General of the Chinese Integrated Chinese and Western Medicine Association Nephrology Committee, Vice Chairman of the Chinese Hospital Management Association Blood Purification Branch, Vice Chairman of the Chinese Medical Promotion Association Blood Purification Branch, Vice President of the World Chinese Nephrologist Association, Member and East China Regional Leader of the Ministry of Health Nephrology Quality Control Center, and Vice President of the Chinese Female Physician Nephrology Association. She has been awarded numerous national awards, including the Fourth National Famous Doctor, the Fifth Chinese Female Physician Science and Technology Award, and the Baosteel Award.

Introduction
Dr. HAN Xiaodong is a multi-practice physician at Shanghai Jiahui Health and serves in the Department of Bariatric and Metabolic Surgery at Shanghai Sixth People’s Hospital. He holds a medical doctorate and is an associate chief physician. Dr. Han earned his Ph.D. in Surgery from Shanghai Jiao Tong University School of Medicine in 2009. Since 2011, he has focused on bariatric surgery, successfully performing over 2,000 procedures. He has contributed to 3 National Natural Science Foundation projects and 2 Shanghai Municipal Science and Technology Commission projects, and has co-authored 10 SCI papers in domestic and international journals, including 7 focused on bariatric and metabolic research. He is the sixth awardee of the Shanghai Medical Science and Technology Second Prize for "New Diagnostic and Therapeutic Technologies for Obesity and Diabetes, and Novel Mechanisms of Pathogenesis." In 2024, he was honored as one of the "Top Ten Public Welfare Figures" at the 10th Annual Medical Excellence Awards by Physician News, China Health Culture Association, and China Health Development Foundation.

Professional Affiliations
• Committee Member, Obesity and Metabolic Disease Surgery Working Group, Surgical Branch of the Chinese Medical Doctor Association
• Member, Bariatric and Metabolic Surgery Group, Surgical Branch of Shanghai Medical Association
• Committee Member, Popular Science Branch of Shanghai Medical Doctor Association
• Standing Committee Member, Endocrinology and Diabetes Branch of the Bethune Spirit Research Association
• Deputy Leader, Popular Science Working Group, Bariatric and Metabolic Rehabilitation Committee of the Chinese Rehabilitation Medical Association
• Co-Chair, Youth Alliance (CYFSO) of the Chinese Journal of Obesity and Metabolic Diseases (Electronic Edition)
• Editorial Board Member, Chinese Journal of Obesity and Metabolic Diseases (Electronic Edition)

ZHUANG Zhigang, MD, PhD., Chief Physician and Administrative Director of the Breast Surgery Department at the Obstetrics and Gynecology Hospital affiliated with Tongji University.

Professional Experience:
Since 2010, Dr. ZHUANG has visited UCLA in the United States, AKH in Austria, and the Mayo Clinic in the United States for academic exchanges and training. He serves as an editorial board member for the Journal of Tongji University. Dr. ZHUANG has led multiple scientific research projects, including the Shanghai Natural Science Foundation, Shanghai Municipal Commission of Health and Family Planning Medical Guidance Projects, and Shanghai Municipal Health Bureau projects. He has also participated in key medical field projects of the Shanghai Municipal Commission of Science and Technology. Dr. ZHUANG is the editor of Common Breast Diseases Consultation and Breast Cancer Consultation, and a contributing author to New Challenges in Communication with Cancer Patients. He has published over 60 papers, including more than 20 SCI-indexed articles, with more than 10 as the first or corresponding author.

Specialties:
• Diagnosis and treatment of benign tumors, breast lumps, nipple discharge, and related breast diseases；
• Diagnosis and treatment of breast cancer and soft tissue tumors；
• Oncoplastic surgery for malignant breast tumors.

Academic Appointments:
• Member of the American Society of Clinical Oncology (ASCO)
• Standing Committee Member of the Tumor Marker Professional Committee of the Chinese Anti-Cancer Association
• Standing Committee Member of the Breast Disease Professional Committee of the China Maternal and Child Health Association
• Member of the Oncoplastic Surgery Branch of the China International Exchange and Promotive Association for Medical and Health Care
• Chairman of the Breast Disease Prevention and Treatment Professional Committee of the Shanghai Maternal and Child Health Association
• Vice Chairman of the Thyroid and Breast Surgery Professional Committee of the Shanghai Association of Integrative Medicine
• Vice Chairman of the Breast Health and Popular Science Committee of the Health Science Branch of the Shanghai Association for Science and Technology
• Standing Committee Member of the Breast Cancer Professional Committee of the Shanghai Anti-Cancer Association
• Standing Committee Member of the Breast Disease Professional Committee of the Shanghai Association of Integrative Medicine

Dr. LYU Jingrong serves as the multi-site practice physician at Jiahui Health. He is titled as Chief Physician and Master’s Supervisor with a doctor degree in Medicine. He is currently the Teaching Director of the Otolaryngology Head and Neck Surgery Department at Shanghai Xinhua Hospital, a national key clinical specialty, and leads the pediatric laryngology and head and neck subspecialty. With extensive experience in clinical work and basic research in otolaryngology, he has published over twenty papers and reviews in authoritative international and domestic journals. He was a visiting scholar at the Massachusetts Eye and Ear Infirmary, Harvard University, USA. His current research focuses on congenital hearing disorders in children and vestibular medicine.

Dr.LYU holds several committee memberships, including:
• Youth Committee Member of the Head and Neck Group, Chinese Anti-Cancer Association Rehabilitation Society
• Youth Committee Member of the Pediatric Otolaryngology Group, Chinese Medical Doctor Association
• Youth Committee Member of the Head and Neck Tumor Expert Committee, Chinese Anti-Cancer Association
• Youth Committee Member of the Academic Guidance Committee, Head and Neck Group, Chinese Anti-Cancer Association Rehabilitation Society
• Youth Committee Member of the Pediatric Otolaryngology Youth Professional Committee, Chinese Medical Doctor Association
• Vice Chairman of the 19th Laryngology Group, 18th Shanghai Medical Association Otolaryngology Head and Neck Surgery Branch
• Member of the 18th Shanghai Otolaryngology Head and Neck Surgery Laryngology Group
• Member of the Head and Neck Surgery Group, 6th Otolaryngology Professional Committee, Shanghai Association of Integrative Medicine

Dr. LYU is proficient in diagnosing and treating various otolaryngological diseases. His main research and clinical focuses include:
1. Minimally invasive surgical treatment for pediatric adenoid hypertrophy, tonsillar hypertrophy, and secretory otitis media.
2. Surgical treatment of congenital neck masses in children, such as thyroglossal duct cysts, branchial cleft cysts, and fistulas.
3. Surgical treatment of neck masses, submandibular gland, and parotid gland tumors in both children and adults, as well as various benign and malignant laryngeal tumors.
4. Minimally invasive surgeries for sinusitis, nasal polyps, and nasal tumors.

His primary scientific research areas include the pathogenesis of pediatric adenoid hypertrophy and its developmental impacts, the pathogenesis of pediatric neck tumors, screening for congenital hearing disorders in children, and medical research related to vestibular development. 

Dr. GE Di, Deputy Director of the Thoracic Surgery Department and Director of the Lung Cancer Center at Zhongshan Hospital, affiliated with Fudan University, doctoral supervisor.

Specialties:
• Differential diagnosis of small pulmonary nodules and management of locally advanced lung cancer;
• Minimally invasive surgery and conventional thoracotomy for lung, esophageal, and mediastinal tumors;
• Carinal surgery, sleeve lobectomy, esophageal resection with colonic interposition, completion pneumonectomy, and radical esophagostomy after partial gastrectomy;

Academic appointment
• Vice Chairman of the Thoracic Surgery Branch of the Shanghai Medical Association;
• Member of the Society of Thoracic Surgeons (STS), USA;
• Fellow of the American College of Chest Physicians (FCCP);
• Vice Chairman of the Thoracic Surgery Branch of the Shanghai Association of Integrative Medicine;
• Member of the Lung Cancer Study Group of the Thoracic and Cardiovascular Surgery Branch of the Chinese Medical Association;
• Vice Chairman of the Lung Cancer Study Group of the Shanghai Anti-Cancer Association;
• Vice Chairman of the Thoracic Surgery Committee of the Chinese Medical Education Association;
• Standing Committee Member of the Thoracic Surgery Professional Committee of the China Medical Foundation;

Specialties: Lower extremity venous diseases, varicose veins, venous ulcers (chronic leg ulcers), vasculitis, venous thrombosis, iliac vein stenosis, and compression.

Introduction:
Dr. TIAN Wen is currently a multi-site practicing physician at Jiahui Health, specializing in the minimally invasive daytime treatment of varicose veins. Trained under the renowned vascular surgery expert Professor Jing Zaiping, Dr. Tian has 10 years of experience in the varicose veins specialty group at Shanghai Changhai Hospital. He is one of the earliest doctors in China to perform daytime local anesthesia surgeries for varicose veins. Currently, he is a member of the venous group in the vascular surgery department at Shanghai First People's Hospital, having completed over 10,000 varicose vein surgeries. His expertise ranges from cosmetic treatments for minor "spider veins" to severe venous ulcers, and from congenital venous malformations to recurrent varicose veins, with a comprehensive treatment system and extensive experience. His primary focus is on the diagnosis and treatment of lower extremity venous reflux diseases and their complications. Dr. Tian has led one Shanghai Municipal Science and Technology Commission fund project and one hospital-level fund project, participated in four National Natural Science Foundation projects, co-authored several academic works including Endovascular Surgery and Devices, and published two SCI papers and two core journal papers in China. He holds a domestic utility model patent and has experience in medical-engineering collaboration, serving as the chief medical consultant for several medical device innovation companies. Dr. Tian has also participated in academic exchanges at Lukas Hospital in Düsseldorf, Germany, the Medical School of the University of Bonn, and the vascular surgery department at Martha Maria Hospital in Nuremberg, and has trained foreign doctors from five countries.

Professional Affiliations:
• Member and Secretary of the Venous Reflux Disease Expert Committee, Chinese Medical Doctor Association
• Member of the Venous Disease Professional Committee, China Senior Citizens Health Association
• Member of the Doctor Group Branch, Chinese Non-Governmental Medical Institutions Association
• Council Member of the Intelligent Diagnosis and Treatment Branch of Chinese and Western Surgery, China Information Association for Traditional Chinese Medicine
• Member of the Vascular Surgery Branch, Shanghai Medical Association

Associate Chief Physician, Associate Chief Physician of Plastic Surgery at Renji Hospital, Shanghai Jiaotong University School of Medicine.

Dr. FU has long been involved in the medical teaching and research work of plastic surgery department, with nearly 30 years of clinical experience and unique insights in body surface tumors, especially facial surgery scar minimization, and assisted other departments such as General Surgery, Breast Surgery, Brain Surgery, Urology and other departments in the repair of wounds after resection of huge tumors, and has long been leading and teaching postgraduates, trainees, and residents of Plastic and Reconstructive Surgery, trainee doctors. She specializes in cosmetic surgery such as body tumor resection wound repair, gynecological plastic surgery, hair transplantation, scar treatment, hand trauma, blepharoplasty eye bags axillary minimally invasive surgery.

Dr. FU was appointed as the eighth and ninth member of Shanghai Medical Association Plastic and Reconstructive Surgery Specialized Branch in 2011 and 2014, the first and second member of Plastic and Reconstructive Surgery Department of Shanghai Medical Doctors Association in 2014 and 2018, and a member of the Shanghai Working Committee of Chinese Physicians Association of Aesthetics and Plastic Surgery Doctors Branch in 2010-2013, and has been recognized as a member of the International Society for Plastic Reconstructive and Aesthetic Surgery, IPRAS. Dr. FU is an inspector with more than 10 years of experience in the Renji group of the Municipal Medical Cosmetology Quality Control Center, and has participated in the city's medical cosmetology quality control inspections twice a year for 15 consecutive years.

Dr. FU participated in writing the chapter of hair transplantation and microsurgical techniques for the Shanghai Plastic Surgery Specialized Training Textbook and the accompanying test questions, and participated in the laboratory and clinical research of the Science and Technology Commission's project, “Experimental Research on the Mechanisms of FAK in Keloid Scar Proliferation and its Gene Therapy”, and authored a total of articles on “Extra-mammary Paget's Disease”, "Expression and Significance of Adhesion Plaque Kinase in Proliferative Keloid Scar Fibroblasts “, ”Study on the function of focal adhensive kinase and integrinα1 in hypertrophic scar fibroblasts" and 5 other papers published in national level professional journals.

Clinical experience
Dr. LI Tao currently serves as an Andrologist at the Fertility and Reproductive Medicine Center of Jiahui Hospital. He holds a Ph.D. degree. Prior to joining Jiahui Hospital, Dr. Li was affiliated with the Obstetrics and Gynecology Hospital of Fudan University (Red House Hospital), where he developed robust theoretical expertise and accumulated over 30 years of clinical experience in male reproductive and urological medicine. He obtained both his M.D. and Ph.D. degrees from Shanghai Jiao Tong University School of Medicine. During his graduate studies, he received mentorship from renowned urology and male reproductive medicine specialists at Renji Hospital, Shanghai Jiao Tong University, including Professors Wang Yixin and Huang Yiran, with a research focus on reproductive biology and urology. Following graduation, Dr. Li pursued clinical and research positions at Shanghai Sixth People’s Hospital and Tongji Hospital. Between 2009 and 2011, he completed postdoctoral research in urology at Ruijin Hospital, Shanghai.

Specializes
Specialize in the treatment of male infertility, including azoospermia, oligospermia, asthenospermia, and teratozoospermia. Proficient in microsurgical procedures pertinent to reproductive andrology, such as vasoepididymostomy (VE), vasovasostomy (VV), varicocelectomy (microsurgical approach), and microdissection testicular sperm extraction (m-TESE); also adept at transurethral aspiration of testicular sperm (TESA) and percutaneous epididymal sperm aspiration (PESA). Skilled in performing endoscopic urogenital surgeries, such as ureteroscopy, cystoscopy, and seminal vesiculoscopy. Possess a robust clinical and theoretical foundation in managing male sexual dysfunction, including erectile dysfunction (ED) and premature ejaculation (PE), as well as in the treatment of urogenital infections, particularly chronic prostatitis.

Research Projets and Awards
As the first author or corresponding author, Dr.Li has published more than ten SCI - indexed articles.He conducted postdoctoral research work at Shanghai Ruijin Hospital, and the relevant research results were published in the internationally renowned urology journal---the Journal of Urology.

Other Awards
Recipient of the Third Prize for Shanghai Science and Technology Progress and the Second Prize for Shanghai Medical Science and Technology.
Co-author of "Andrology Therapeutics" (Science and Technology Documentation Press, Beijing, 2002) and "Surgical Oncology of the Genitourinary System" (People's Medical Publishing House, Beijing, 2011).
Independent fulfillment of a General Project (Category A) under the 2010 Postdoctoral Research Sponsorship Program of Shanghai.